SAT-094 Evaluation of IGF-1 as a Biomarker to Inform Phase 3 Clinical Trial Design and Dose Selection in Patients Born Small for Gestational Age Who Fail to Demonstrate Catch-Up Gr...

por Liu, Tao, Penzenstadler, Justin, Cicali, Brain, Zemskova, Marina S, Vaidyanathan, Jayabharathi, Sahajwalla, Chandrahas
Publicado 2020